JP2023036007A5 - - Google Patents

Download PDF

Info

Publication number
JP2023036007A5
JP2023036007A5 JP2022136673A JP2022136673A JP2023036007A5 JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5 JP 2022136673 A JP2022136673 A JP 2022136673A JP 2022136673 A JP2022136673 A JP 2022136673A JP 2023036007 A5 JP2023036007 A5 JP 2023036007A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
group
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022136673A
Other languages
English (en)
Japanese (ja)
Other versions
JP7483810B2 (ja
JP2023036007A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023036007A publication Critical patent/JP2023036007A/ja
Publication of JP2023036007A5 publication Critical patent/JP2023036007A5/ja
Priority to JP2024074339A priority Critical patent/JP2024112817A/ja
Application granted granted Critical
Publication of JP7483810B2 publication Critical patent/JP7483810B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022136673A 2021-08-31 2022-08-30 6-アミノピラゾロピリミジン化合物及びその医薬用途 Active JP7483810B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024074339A JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021141253 2021-08-31
JP2021141253 2021-08-31
JP2022068967 2022-04-19
JP2022068967 2022-04-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024074339A Division JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2023036007A JP2023036007A (ja) 2023-03-13
JP2023036007A5 true JP2023036007A5 (https=) 2024-01-11
JP7483810B2 JP7483810B2 (ja) 2024-05-15

Family

ID=85411220

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022136673A Active JP7483810B2 (ja) 2021-08-31 2022-08-30 6-アミノピラゾロピリミジン化合物及びその医薬用途
JP2024074339A Withdrawn JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024074339A Withdrawn JP2024112817A (ja) 2021-08-31 2024-05-01 6-アミノピラゾロピリミジン化合物及びその医薬用途

Country Status (15)

Country Link
US (1) US20240287079A1 (https=)
EP (1) EP4397663A4 (https=)
JP (2) JP7483810B2 (https=)
KR (1) KR20240055035A (https=)
AR (1) AR126912A1 (https=)
AU (1) AU2022340126A1 (https=)
CA (1) CA3229401A1 (https=)
CL (1) CL2024000581A1 (https=)
CO (1) CO2024002515A2 (https=)
IL (1) IL310062A (https=)
MX (1) MX2024002609A (https=)
PE (1) PE20240882A1 (https=)
TW (1) TW202328134A (https=)
WO (1) WO2023032987A1 (https=)
ZA (1) ZA202400656B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250114361A1 (en) * 2022-08-29 2025-04-10 Japan Tobacco Inc. Pyrazolopyrimidine compound and pharmaceutical use thereof
IL322520A (en) * 2023-02-24 2025-10-01 Japan Tobacco Inc Modified pyrazolopyrimidine compounds and their medical use
JP7729000B2 (ja) * 2023-02-24 2025-08-25 日本たばこ産業株式会社 6-アルコキシピラゾロピリミジン化合物及びその医薬用途
KR20250170647A (ko) 2023-04-14 2025-12-05 다케다 야쿠힌 고교 가부시키가이샤 Nlrp3 억제제로서의 피라졸로피리미딘 유도체
KR20260027946A (ko) 2023-06-02 2026-03-03 머크 샤프 앤드 돔 엘엘씨 Nod-유사 수용체 단백질 3의 억제제로서 유용한 5,6 불포화 비시클릭 헤테로사이클
US20250195511A1 (en) * 2023-12-14 2025-06-19 Merck Sharp & Dohme Llc Indazole derivatives useful as inhibitors of nod-like receptor protein 3
TW202532066A (zh) * 2023-12-14 2025-08-16 美商默沙東有限責任公司 作為nod樣受體蛋白3抑制劑之氮雜吲唑衍生物
WO2025140708A1 (zh) * 2023-12-31 2025-07-03 杭州百新生物医药科技有限公司 吡唑并嘧啶类化合物及其医药用途
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2013007253A0 (en) * 2011-04-21 2013-11-30 Origenis Gmbh Pyrazolo [4,3-D] pyrimidines useful as kinase inhibitors
WO2017205766A1 (en) * 2016-05-27 2017-11-30 Pharmacyclics Llc Inhibitors of interleukin-1 receptor-associated kinase
WO2020150114A1 (en) * 2019-01-14 2020-07-23 Innate Tumor Immunity, Inc. Heterocyclic nlrp3 modulators, for use in the treatment of cancer
US12391675B2 (en) * 2019-01-14 2025-08-19 Innate Tumor Immunity, Inc. NLRP3 modulators

Similar Documents

Publication Publication Date Title
JP2023036007A5 (https=)
JP2024032686A5 (https=)
JP2024050527A5 (https=)
RU2472509C2 (ru) Способ лечения артрита
JP2024120882A5 (https=)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2014506907A5 (https=)
RU2005127356A (ru) Новая кристаллическая форма триазоло (4,5-d) пиримидина
JPWO2024177126A5 (https=)
JP2012521994A5 (https=)
JP2020507589A5 (https=)
JP2016510769A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
RS53467B (sr) Upotreba amisulprida za tretiranje mučnine i povraćanja izazvanih hemoterapijom
IL296282B2 (en) Fluorophenyl beta-hydroxyethylamines and their uses in the treatment of hyperglycemia
JP2019529444A5 (https=)
JP2005502621A5 (https=)
JP2018534288A5 (https=)
JP2020511536A5 (https=)
JP2019518779A5 (https=)
JP2010505865A5 (https=)
JP2020531463A5 (https=)
JP2018509426A5 (https=)
JP2022510587A5 (https=)